Perazine-d8 is a deuterated form of perazine, which is an antipsychotic medication primarily used to treat schizophrenia and other psychotic disorders. The "d8" designation indicates that the compound has been labeled with deuterium, a stable isotope of hydrogen, replacing eight hydrogen atoms in the molecule. This modification can enhance the compound's stability and alter its pharmacokinetic properties, making it useful in research applications, particularly in studies involving drug metabolism and distribution. Perazine itself functions as a dopamine antagonist, primarily affecting D2 receptors in the brain, which helps to mitigate symptoms of psychosis. The deuterated version may also be employed in various analytical techniques, such as nuclear magnetic resonance (NMR) spectroscopy, to provide clearer insights into molecular interactions and dynamics. As with any pharmaceutical compound, safety and efficacy are paramount, and the use of deuterated compounds in clinical settings is typically subject to rigorous regulatory scrutiny.

Perazine-d8

1246815-57-5: Perazine-d8 is a deuterated form of perazine, which is an antipsychotic medication primarily used to treat schizophrenia and other psychotic disorders. The "d8" designation indicates that the compound has been labeled with deuterium, a stable isotope of hydrogen, replacing eight hydrogen atoms in the molecule. This modification can enhance the compound's stability and alter its pharmacokinetic properties, making it useful in research applications, particularly in studies involving drug metabolism and distribution. Perazine itself functions as a dopamine antagonist, primarily affecting D2 receptors in the brain, which helps to mitigate symptoms of psychosis. The deuterated version may also be employed in various analytical techniques, such as nuclear magnetic resonance (NMR) spectroscopy, to provide clearer insights into molecular interactions and dynamics. As with any pharmaceutical compound, safety and efficacy are paramount, and the use of deuterated compounds in clinical settings is typically subject to rigorous regulatory scrutiny.

<p>Applications Antipsychotic.<br>References Hromatka, et al.: Monatsh. Chem., 88, 56 (1957), Franke, U., et al.: J. Pharm. Sci., 88, 89 (1999), Hashem, H., et al.: Pharmazie, 60, 186 (2005),<br></p>

CAS 1246815-57-5

Perazine-d8

Perazine-d8 Dihydrochloride Salt

Ref: TR-P285802

Perazine-d8 Dihydrochloride Salt

Ref: IN-DA01CC2A